Hinge Health (HNGE) - 11.98% Below 52-Week High: Buy or Wait?

Stock Details

Hinge Health, Inc. (HNGE), a prominent company in the healthcare sector within the health information services industry, is based in United States and primarily trades on the NYQ.Currently, the stock is trading at $54.73. Over the past 52 weeks, it has ranged between $30.08 and $62.18. This places the current price at 88.0% of its 52-week high and 81.9% above its 52-week low. Recent trading volume was recorded at 1,781,886. The 14-day Relative Strength Index (RSI) stands at 58.63, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $41.75 by 31.09%. Similarly, it is above its 200-day moving average of $47.01 by 16.42%. The MACD histogram is 0.25, indicating bullish momentum (MACD Line: 1.51, Signal Line: 1.27). There is currently 1 active alert set for HNGE by users.

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

17.94

Price to Book

38.77

EV/EBITDA

-8.04

EPS (TTM)

-$8.91

Price to Sales

6.71

Q:How is HNGE valued relative to its earnings and growth?

Valuation data is not available for this stock.

Q:What is HNGE's risk profile compared to the market?

Risk profile data is not available for this stock.

Performance & Growth

Profit Margin

-78.95%

Operating Margin

17.59%

EBITDA

$-525,336,000

Return on Equity

-136.00%

Return on Assets

-45.74%

Revenue Growth (YoY)

47.20%

Earnings Growth (YoY)

-68.40%

Q:How profitable and efficient is HNGE's business model?

Hinge Health, Inc. achieves a profit margin of -78.95%, meaning it retains $-78.95 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 17.59% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -136.00% and ROA at -45.74%, the company achieves moderate returns on invested capital.

Q:What are HNGE's recent growth trends?

Hinge Health, Inc.'s revenue grew by 47.20% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. Earnings decreased by 68.40% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against Health Information Services industry averages for proper context.

Company Size & Market

Market Cap

$4.3B

Revenue (TTM)

$646.34M

Revenue/Share (TTM)

$9.18

Shares Outstanding

54.66M

Book Value/Share

$1.45

Asset Type

EQUITY

Q:What is HNGE's market capitalization and position?

Hinge Health, Inc. has a market capitalization of $4.3B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 54.66M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Health Information Services industry, it competes with other firms in this sector.

Q:How does HNGE's price compare to its book value?

Hinge Health, Inc.'s book value per share is $1.45, while the current stock price is $54.73, resulting in a price-to-book (P/B) ratio of 37.88. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$69.93

27.78% upside potential

Analyst Recommendations

Strong Buy

Buy

Hold

Sell

Strong Sell

Q:How reliable are analyst predictions for HNGE?

15 analysts cover HNGE with 93% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $69.93 implies 27.8% upside, but targets are often adjusted to follow price moves rather than predict them.

Q:What is the Wall Street consensus on HNGE?

Current analyst recommendations:7 Strong Buy, 7 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: May 11, 2026, 02:18 AM

Technical Indicators

RSI (14-day)

58.63

Neutral

50-Day Moving Average

$41.75

31.09% above MA-50

200-Day Moving Average

$47.01

16.42% above MA-200

MACD Line

1.51

MACD Signal

1.27

MACD Histogram

0.25

Bullish

Q:What does HNGE's RSI value tell investors?

The RSI (Relative Strength Index) for HNGE is currently 58.63, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.

Q:How should traders interpret HNGE's MACD and moving average crossovers?

MACD analysis shows the MACD line at 1.51 above the signal line at 1.27, with histogram at 0.25. This bullish crossover suggests upward momentum is building. The 50-day MA ($41.75) is below the 200-day MA ($47.01), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Mar 16, 2026, 10:43 AM

Condition	Threshold	Created At
Price falls below	$21.00	Nov 21, 2025, 03:04 PM

Condition

Threshold

Created At

Price falls below

$21.00

Nov 21, 2025, 03:04 PM

Hinge Health, Inc. (HNGE) Stock